Nabiximols, an oromucosal spray of an entire cannabis plant extract having a one:1 ratio of THC to cannabidiol (CBD), was in the beginning certified and permitted in Europe, the United Kingdom, and copyright for that procedure of soreness and spasticity associated with many sclerosis (GW Pharmaceutical